Skip to main content

Genstruct Licenses Pathway Database from Jubilant Biosys

NEW YORK, April 27 (GenomeWeb News) - Jubilant Biosys, of Bangalore, India, said today that it has licensed its PathArt database of biochemical pathways to Genstruct for use in that company's drug discovery programs.


Genstruct will use the database to enhance its Molecular Epistemics platform for the discovery and definition of compound mechanism of action and biomarkers.


According to Jubilant, PathArt contains over 600 manually curated signaling, metabolic, and disease-specific pathways, including diseases such as cancer, arthritis, Alzheimer's, asthma, multiple sclerosis, Parkinson's, diabetes, and atherosclerosis.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.